A combined sequencing technique assesses 18 patients with high-grade serous ovarian cancer over a multi-year period from diagnosis to recurrence and shows drug resistance typically arises from selective expansion of one or a few clones present at diagnosis.
- Marc J. Williams
- Ignacio Vázquez-García
- Sohrab P. Shah